{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:43:48Z","timestamp":1788587028892,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82570903"],"award-info":[{"award-number":["82570903"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04353-8","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:34:25Z","timestamp":1773214465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multi-omics study on tumor-associated macrophages remodeling the tumor microenvironment via the CXCL5-CXCR2 axis to drive immune escape in bladder cancer"],"prefix":"10.1007","volume":"75","author":[{"given":"Yunzhong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxuan","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchun","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhai","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"1","key":"4353_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.eururo.2021.09.026","volume":"81","author":"R Cathomas","year":"2022","unstructured":"Cathomas R, Lorch A, Bruins HM et al (2022) The 2021 updated European Association of Urology guidelines on metastatic urothelial carcinoma. Eur Urol 81(1):95\u2013103","journal-title":"Eur Urol"},{"key":"4353_CR2","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.21037\/tau-20-1472","volume":"10","author":"N Giudici","year":"2021","unstructured":"Giudici N, Bonne F, Blarer J, Minoli M, Krentel F, Seiler R (2021) Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review. Transl Androl Urol 10:4036\u20134050","journal-title":"Transl Androl Urol"},{"key":"4353_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110158","volume":"119","author":"Q Tang","year":"2023","unstructured":"Tang Q, Li S, Huang G, Liu H (2023) Research progress on PD-1 and PD-L1 inhibitors in the treatment of metastatic urothelial carcinoma. Int Immunopharmacol 119:110158","journal-title":"Int Immunopharmacol"},{"key":"4353_CR4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/S1470-2045(17)30616-2","volume":"18","author":"AV Balar","year":"2017","unstructured":"Balar AV, Castellano D, O\u2019Donnell PH, Grivas P, Vuky J, Powles T et al (2017) First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol 18:1483\u20131492","journal-title":"Lancet Oncol"},{"key":"4353_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","volume":"14","author":"SP Patel","year":"2015","unstructured":"Patel SP, Kurzrock R (2015) PD-L1 expression as a predictive biomarker in cancer immunotherapy. Mol Cancer Ther 14:847\u2013856","journal-title":"Mol Cancer Ther"},{"key":"4353_CR6","doi-asserted-by":"publisher","first-page":"earr3593","DOI":"10.1126\/science.aar3593","volume":"362","author":"R Cristescu","year":"2018","unstructured":"Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J et al (2018) Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science 362:earr3593","journal-title":"Science"},{"key":"4353_CR7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","volume":"114","author":"C Ngambenjawong","year":"2017","unstructured":"Ngambenjawong C, Gustafson HH, Pun SH (2017) Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev 114:206\u2013221","journal-title":"Adv Drug Deliv Rev"},{"key":"4353_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000518664","volume":"8","author":"L Tian","year":"2022","unstructured":"Tian L, Lei A, Tan T, Zhu M, Zhang L, Mou H et al (2022) Macrophage-based combination therapies as a new strategy for cancer immunotherapy. Kidney Dis (Basel) 8:26\u201343","journal-title":"Kidney Dis (Basel)"},{"key":"4353_CR9","volume":"13","author":"L Jaramillo-Valverde","year":"2021","unstructured":"Jaramillo-Valverde L, Levano KS, Capristano S, Tarazona DD, Cisneros A, Yufra-Picardo VM et al (2021) CXCR4 Knockdown Via CRISPR\/CAS9 in a tumor-associated macrophage model decreases human breast cancer cell migration. Cureus 13:e20842","journal-title":"Cureus"},{"key":"4353_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1133238","volume":"14","author":"Y Miao","year":"2023","unstructured":"Miao Y, Wang S, Zhang B, Liu L (2023) Carbon dot-based nanomaterials: a promising future nano-platform for targeting tumor-associated macrophages. Front Immunol 14:1133238","journal-title":"Front Immunol"},{"key":"4353_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008668","volume":"5","author":"M Daigneault","year":"2010","unstructured":"Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH (2010) The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 5:e8668","journal-title":"PLoS ONE"},{"key":"4353_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41423-024-01216-z","volume":"21","author":"A Mantovani","year":"2024","unstructured":"Mantovani A, Marchesi F, Di Mitri D, Garlanda C (2024) Macrophage diversity in cancer dissemination and metastasis. Cell Mol Immunol 21:1201\u20131214","journal-title":"Cell Mol Immunol"},{"key":"4353_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma RY, Black A, Qian BZ (2022) Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol 43:546\u2013563","journal-title":"Trends Immunol"},{"key":"4353_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nature13904","volume":"515","author":"T Powles","year":"2014","unstructured":"Powles T, Eder JP, Fine GD, Braiteh FS, Loriot Y, Cruz C et al (2014) MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature 515:558\u2013562","journal-title":"Nature"},{"key":"4353_CR15","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg JE, Hoffman-Censits J, Powles T, van der Heijden MS, Balar AV, Necchi A et al (2016) Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet 387:1909\u20131920","journal-title":"Lancet"},{"key":"4353_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","volume":"36","author":"A Zlotnik","year":"2012","unstructured":"Zlotnik A, Yoshie O (2012) The chemokine superfamily revisited. Immunity 36:705\u2013716","journal-title":"Immunity"},{"key":"4353_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","volume":"10","author":"AE Vilgelm","year":"2019","unstructured":"Vilgelm AE, Richmond A (2019) Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy. Front Immunol 10:333","journal-title":"Front Immunol"},{"key":"4353_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/cancers15010167","volume":"15","author":"T Wu","year":"2022","unstructured":"Wu T, Yang W, Sun A, Wei Z, Lin Q (2022) The role of cxc chemokines in cancer progression. Cancers (Basel) 15:167","journal-title":"Cancers (Basel)"},{"key":"4353_CR19","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y et al (2020) Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun 11:5077","journal-title":"Nat Commun"},{"key":"4353_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y et al (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554:544\u2013548","journal-title":"Nature"},{"key":"4353_CR21","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48:W509\u2013W514","journal-title":"Nucleic Acids Res"},{"key":"4353_CR22","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/s43018-024-00822-0","volume":"5","author":"K Li","year":"2024","unstructured":"Li K, Zhong W, Fan J, Wang S, Yu D, Xu T et al (2024) Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial. Nat Cancer 5:1465\u20131478","journal-title":"Nat Cancer"},{"key":"4353_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R (2018) Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36:411\u2013420","journal-title":"Nat Biotechnol"},{"key":"4353_CR24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K et al (2019) Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods 16:1289\u20131296","journal-title":"Nat Methods"},{"key":"4353_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giy083","volume":"7","author":"L Zappia","year":"2018","unstructured":"Zappia L, Oshlack A (2018) Clustering trees: a visualization for evaluating clusterings at multiple resolutions. Gigascience 7:giy083","journal-title":"Gigascience"},{"key":"4353_CR26","doi-asserted-by":"publisher","first-page":"D870","DOI":"10.1093\/nar\/gkac947","volume":"51","author":"C Hu","year":"2023","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J et al (2023) Cell Marker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res 51:D870\u2013D876","journal-title":"Nucleic Acids Res"},{"key":"4353_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y et al (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453\u2013457","journal-title":"Nat Methods"},{"key":"4353_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-0716-3072-3_19","volume":"2649","author":"A Coleman","year":"2023","unstructured":"Coleman A, Bose A, Mitra S (2023) Metagenomics data visualization using R. Methods Mol Biol 2649:359\u2013392","journal-title":"Methods Mol Biol"},{"key":"4353_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"},{"key":"4353_CR30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284\u2013287","journal-title":"OMICS"},{"key":"4353_CR31","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y et al (2021) A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184:792-809.e23","journal-title":"Cell"},{"key":"4353_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA et al (2017) Reversed graph embedding resolves complex single-cell trajectories. Nat Methods 14:979\u2013982","journal-title":"Nat Methods"},{"key":"4353_CR33","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonz\u00e1lez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G et al (2017) SCENIC: single-cell regulatory network inference and clustering. Nat Methods 14:1083\u20131086","journal-title":"Nat Methods"},{"key":"4353_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41587-021-01091-3","volume":"4","author":"D Sun","year":"2022","unstructured":"Sun D, Guan X, Moran AE, Wu LY, Qian DZ, Schedin P et al (2022) Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol 4:527\u2013538","journal-title":"Nat Biotechnol"},{"key":"4353_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14:7","journal-title":"BMC Bioinformatics"},{"key":"4353_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2019.112721","volume":"478","author":"EW Baxter","year":"2020","unstructured":"Baxter EW, Graham AE, Re NA, Carr IM, Robinson JI, Mackie SL et al (2020) Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFN\u03b3+LPS), M(IL-4) and M(IL-10) phenotypes. J Immunol Methods 478:112721","journal-title":"J Immunol Methods"},{"key":"4353_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF (2021) Macrophage polarization states in the tumor microenvironment. Int J Mol Sci 22:6995","journal-title":"Int J Mol Sci"},{"key":"4353_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109569","volume":"116","author":"S Cheruku","year":"2023","unstructured":"Cheruku S, Rao V, Pandey R, Rao Chamallamudi M, Velayutham R, Kumar N (2023) Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: current research in macrophage repolarization immunotherapy. Int Immunopharmacol 116:109569","journal-title":"Int Immunopharmacol"},{"key":"4353_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13101724","volume":"13","author":"Y Yang","year":"2023","unstructured":"Yang Y, Lu T, Jia X, Gao Y (2023) FSTL1 suppresses triple-negative breast cancer lung metastasis by inhibiting M2-like tumor-associated macrophage recruitment toward the lungs. Diagnostics (Basel) 13:1724","journal-title":"Diagnostics (Basel)"},{"key":"4353_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1141034","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu J, Piranlioglu R, Ye F, Shu K, Lei T, Nakashima H (2023) Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions. Front Cell Infect Microbiol 13:1141034","journal-title":"Front Cell Infect Microbiol"},{"key":"4353_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126526","volume":"22","author":"MT Munir","year":"2021","unstructured":"Munir MT, Kay MK, Kang MH, Rahman MM, Al-Harrasi A, Choudhury M et al (2021) Tumor-associated macrophages as multifaceted regulators of breast tumor growth. Int J Mol Sci 22:6526","journal-title":"Int J Mol Sci"},{"key":"4353_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168470","volume":"22","author":"H Wang","year":"2021","unstructured":"Wang H, Tian T, Zhang J (2021) Tumor-associated macrophages (TAMs) in colorectal cancer (CRC): From mechanism to therapy and prognosis. Int J Mol Sci 22:8470","journal-title":"Int J Mol Sci"},{"key":"4353_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006808","volume":"11","author":"J Xu","year":"2023","unstructured":"Xu J, Shi Q, Lou J, Wang B, Wang W, Niu J et al (2023) Chordoma recruits and polarizes tumor-associated macrophages via secreting CCL5 to promote malignant progression. J Immunother Cancer 11:e006808","journal-title":"J Immunother Cancer"},{"key":"4353_CR44","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1167\/iovs.09-4255","volume":"51","author":"Y Pi\u00f1a","year":"2010","unstructured":"Pi\u00f1a Y, Boutrid H, Murray TG, Jager MJ, Cebulla CM, Schefler A et al (2010) Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype. Invest Ophthalmol Vis Sci 51:2671\u20132677","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4353_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/path.6151","volume":"261","author":"Y Feng","year":"2023","unstructured":"Feng Y, Wang S, Xie J, Ding B, Wang M, Zhang P et al (2023) Spatial transcriptomics reveals heterogeneity of macrophages in the tumor microenvironment of granulomatous slack skin. J Pathol 261:105\u2013119","journal-title":"J Pathol"},{"key":"4353_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12967-023-04281-6","volume":"21","author":"Z Peng","year":"2023","unstructured":"Peng Z, Ren Z, Tong Z, Zhu Y, Zhu Y, Hu K (2023) Interactions between MFAP5 + fibroblasts and tumor-infiltrating myeloid cells shape the malignant microenvironment of colorectal cancer. J Transl Med 21:405","journal-title":"J Transl Med"},{"key":"4353_CR47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41417-023-00704-0","volume":"31","author":"J Wu","year":"2024","unstructured":"Wu J, Shen Y, Zeng G, Liang Y, Liao G (2024) SPP1(+) TAM subpopulations in tumor microenvironment promote intravasation and metastasis of head and neck squamous cell carcinoma. Cancer Gene Ther 31:311\u2013321","journal-title":"Cancer Gene Ther"},{"key":"4353_CR48","doi-asserted-by":"publisher","first-page":"1194199","DOI":"10.3389\/fcell.2023.1194199","volume":"11","author":"J Gao","year":"2023","unstructured":"Gao J, Li Z, Lu Q, Zhong J, Pan L, Feng C et al (2023) Single-cell RNA sequencing reveals cell subpopulations in the tumor microenvironment contributing to hepatocellular carcinoma. Front Cell Dev Biol 11:1194199","journal-title":"Front Cell Dev Biol"},{"key":"4353_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184374","volume":"14","author":"E Matsubara","year":"2022","unstructured":"Matsubara E, Komohara Y, Esumi S, Shinchi Y, Ishizuka S, Mito R et al (2022) SPP1 derived from macrophages is associated with a worse clinical course and chemo-resistance in lung adenocarcinoma. Cancers (Basel) 14:4374","journal-title":"Cancers (Basel)"},{"key":"4353_CR50","doi-asserted-by":"publisher","first-page":"1184167","DOI":"10.3389\/fimmu.2023.1184167","volume":"14","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Liu Y, Wang X, Zhang C, Hou M, Liu Y (2023) Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis. Front Immunol 14:1184167","journal-title":"Front Immunol"},{"key":"4353_CR51","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2022.02.021","volume":"185","author":"R Nalio Ramos","year":"2022","unstructured":"Nalio Ramos R, Missolo-Koussou Y, Gerber-Ferder Y, Bromley CP, Bugatti M, N\u00fa\u00f1ez NG et al (2022) Tissue-resident FOLR2(+) macrophages associate with CD8(+) T cell infiltration in human breast cancer. Cell 185:1189-1207.e25","journal-title":"Cell"},{"key":"4353_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06021-6","volume":"14","author":"C Xiang","year":"2023","unstructured":"Xiang C, Zhang M, Shang Z, Chen S, Zhao J, Ding B et al (2023) Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma. Cell Death Dis 14:493","journal-title":"Cell Death Dis"},{"key":"4353_CR53","doi-asserted-by":"publisher","first-page":"930352","DOI":"10.3389\/fimmu.2022.930352","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Qu X, Zhang M, Zhang L, Yang T, Ma M et al (2022) Identification of a six-gene prognostic signature for bladder cancer associated macrophage. Front Immunol 13:930352","journal-title":"Front Immunol"},{"key":"4353_CR54","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","volume":"623","author":"N Caronni","year":"2023","unstructured":"Caronni N, La Terza F, Vittoria FM, Barbiera G, Mezzanzanica L, Cuzzola V et al (2023) IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer. Nature 623:415\u2013422","journal-title":"Nature"},{"key":"4353_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206889","volume":"10","author":"D Wang","year":"2023","unstructured":"Wang D, Cheng C, Chen X, Wang J, Liu K, Jing N et al (2023) IL-1\u03b2 is an androgen-responsive target in macrophages for immunotherapy of prostate cancer. Adv Sci (Weinh) 10:e2206889","journal-title":"Adv Sci (Weinh)"},{"key":"4353_CR56","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma P, Goswami S, Raychaudhuri D, Siddiqui BA, Singh P, Nagarajan A et al (2023) Immune checkpoint therapy-current perspectives and future directions. Cell 186:1652\u20131669","journal-title":"Cell"},{"key":"4353_CR57","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1470-2045(17)30846-X","volume":"19","author":"JA Beaver","year":"2018","unstructured":"Beaver JA, Hazarika M, Mulkey F, Mushti S, Chen H, He K et al (2018) Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis. Lancet Oncol 19:229\u2013239","journal-title":"Lancet Oncol"},{"key":"4353_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-020-01786-6","volume":"40","author":"W Fang","year":"2021","unstructured":"Fang W, Zhou T, Shi H, Yao M, Zhang D, Qian H et al (2021) Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion. J Exp Clin Cancer Res 40:4","journal-title":"J Exp Clin Cancer Res"},{"key":"4353_CR59","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1084\/jem.20090847","volume":"206","author":"LM Francisco","year":"2009","unstructured":"Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK et al (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206:3015\u20133029","journal-title":"J Exp Med"},{"key":"4353_CR60","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1158\/0008-5472.CAN-16-3453","volume":"77","author":"AK Mattox","year":"2017","unstructured":"Mattox AK, Lee J, Westra WH, Pierce RH, Ghossein R, Faquin WC et al (2017) PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4(+) TILs in the Presence of PD-L1(+) TAMs. Cancer Res 77:6365\u20136374","journal-title":"Cancer Res"},{"key":"4353_CR61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/gutjnl-2020-322744","volume":"71","author":"X Sun","year":"2022","unstructured":"Sun X, He X, Zhang Y, Hosaka K, Andersson P, Wu J et al (2022) Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Gut 71:129\u2013147","journal-title":"Gut"},{"key":"4353_CR62","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41418-019-0460-0","volume":"27","author":"C Liu","year":"2020","unstructured":"Liu C, Yao Z, Wang J, Zhang W, Yang Y, Zhang Y et al (2020) Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65\/STAT3-CSN5-PD-L1 pathway. Cell Death Differ 27:1765\u20131781","journal-title":"Cell Death Differ"},{"key":"4353_CR63","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1136\/gutjnl-2021-326350","volume":"71","author":"L Lu","year":"2022","unstructured":"Lu L, Zhou Z, Wang X, Liu B, Lu J, Liu S et al (2022) PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma. Gut 71:2551\u20132560","journal-title":"Gut"},{"key":"4353_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101420","volume":"5","author":"L Wang","year":"2024","unstructured":"Wang L, Guo W, Guo Z, Yu J, Tan J, Simons DL et al (2024) PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer. Cell Rep Med 5:101420","journal-title":"Cell Rep Med"},{"key":"4353_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1615\/CritRevImmunol.2014010062","volume":"34","author":"AV Gorbachev","year":"2014","unstructured":"Gorbachev AV, Fairchild RL (2014) Regulation of chemokine expression in the tumor microenvironment. Crit Rev Immunol 34:103\u2013120","journal-title":"Crit Rev Immunol"},{"key":"4353_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-322","volume":"13","author":"M Miyake","year":"2013","unstructured":"Miyake M, Lawton A, Goodison S, Urquidi V, Gomes-Giacoia E, Zhang G et al (2013) Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers. BMC Cancer 13:322","journal-title":"BMC Cancer"},{"key":"4353_CR67","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3892\/ijo.2015.3041","volume":"47","author":"Y Gao","year":"2015","unstructured":"Gao Y, Guan Z, Chen J, Xie H, Yang Z, Fan J et al (2015) CXCL5\/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K\/AKT-induced upregulation of MMP2\/MMP9. Int J Oncol 47:690\u2013700","journal-title":"Int J Oncol"},{"key":"4353_CR68","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W (2017) Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol 17:559\u2013572","journal-title":"Nat Rev Immunol"},{"key":"4353_CR69","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/stem.1194","volume":"30","author":"H Long","year":"2012","unstructured":"Long H, Xie R, Xiang T, Zhao Z, Lin S, Liang Z et al (2012) Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-\u03baB-mediated MMP-9 upregulation. Stem Cells 30:2309\u20132319","journal-title":"Stem Cells"},{"key":"4353_CR70","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1158\/0008-5472.CAN-18-1702","volume":"78","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Shurin GV, Zhong H, Bunimovich YL, Han B, Shurin MR (2018) Schwann cells augment cell spreading and metastasis of lung cancer. Cancer Res 78:5927\u20135939","journal-title":"Cancer Res"},{"key":"4353_CR71","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/ijc.32278","volume":"145","author":"Z Li","year":"2019","unstructured":"Li Z, Zhou J, Zhang J, Li S, Wang H, Du J (2019) Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5. Int J Cancer 145:1946\u20131957","journal-title":"Int J Cancer"},{"key":"4353_CR72","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood-2018-11-844548","volume":"133","author":"MA Giese","year":"2019","unstructured":"Giese MA, Hind LE, Huttenlocher A (2019) Neutrophil plasticity in the tumor microenvironment. Blood 133:2159\u20132167","journal-title":"Blood"},{"key":"4353_CR73","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI (2021) Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol 21:485\u2013498","journal-title":"Nat Rev Immunol"},{"key":"4353_CR74","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1002\/ijc.25631","volume":"128","author":"JA Karam","year":"2011","unstructured":"Karam JA, Huang S, Fan J, Stanfield J, Schultz RA, Pong RC et al (2011) Upregulation of TRAG3 gene in urothelial carcinoma of the bladder. Int J Cancer 128:2823\u20132832","journal-title":"Int J Cancer"},{"key":"4353_CR75","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/CAD.0000000000001153","volume":"33","author":"W Wang","year":"2022","unstructured":"Wang W, Zhang M, Huang Z, Wang L, Yue Y, Wang X et al (2022) Knockdown of CXCL5 inhibits the invasion, metastasis and stemness of bladder cancer lung metastatic cells by downregulating CD44. Anticancer Drugs 33:103\u2013112","journal-title":"Anticancer Drugs"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04353-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:02:38Z","timestamp":1773219758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04353-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":75,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["4353"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04353-8","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved and supervised by the Ethical Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China (NO.2022018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"103"}}